EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+7.18%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$291M
AUM Growth
+$291M
(+18%)
Cap. Flow
+$30.6M
Cap. Flow
% of AUM
10.49%
Top 10 Holdings %
Top 10 Hldgs %
61.7%
Holding
30
New
6
Increased
13
Reduced
4
Closed
1
Top Buys
| 1 |
American Well
AMWL
|
$9.15M |
| 2 |
DexCom
DXCM
|
$8.71M |
| 3 |
Outset Medical
OM
|
$4.43M |
| 4 |
Privia Health
PRVA
|
$4.26M |
| 5 |
Inspire Medical Systems
INSP
|
$3.59M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$9.56M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$6.57M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$3.69M |
| 4 |
IQVIA
IQV
|
$3.61M |
| 5 |
Natera
NTRA
|
$590K |
Sector Composition
| 1 | Healthcare | 97.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AstraZeneca
AZN
$248B
| $23.9M | 8.22% |
399,789
+43,000
| +12% | +$2.58M |
|
2
Humana
HUM
$36.5B
| $21.1M | 7.25% |
47,721
+2,800
| +6% | +$1.24M |
|
|
3
IQVIA
IQV
$32.4B
| $20.7M | 7.09% |
85,277
-14,900
| -15% | -$3.61M |
|
|
4
Natera
NTRA
$23.1B
| $18.5M | 6.36% |
163,194
-5,200
| -3% | -$590K |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $18.3M | 6.29% |
108,179
| – | – |
|
6
United Therapeutics
UTHR
$13.8B
| $17.6M | 6.03% |
98,038
+4,938
| +5% | +$886K |
|
7
argenx
ARGX
$43.6B
| $16M | 5.5% |
53,232
+10,600
| +25% | +$3.19M |
|
|
AXNX
8
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.9M | 5.1% |
234,565
+39,600
| +20% | +$2.51M |
|
|
9
DexCom
DXCM
$29.5B
| $14.6M | 5.01% |
34,200
+20,400
| +148% | +$8.71M |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $14.1M | 4.85% |
70,144
-18,300
| -21% | -$3.69M |
|
|
11
Agios Pharmaceuticals
AGIO
$2.19B
| $13M | 4.45% |
235,513
-119,137
| -34% | -$6.57M |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $12.4M | 4.25% |
140,763
+7,600
| +6% | +$669K |
|
|
13
Inspire Medical Systems
INSP
$2.77B
| $10.8M | 3.72% |
56,053
+18,600
| +50% | +$3.59M |
|
14
Adaptive Biotechnologies
ADPT
$2.01B
| $10.5M | 3.61% |
257,827
+55,607
| +27% | +$2.27M |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.35M | 3.21% |
57,900
+21,500
| +59% | +$3.47M |
|
|
16
Outset Medical
OM
$247M
| $9.3M | 3.19% |
186,000
+88,700
| +91% | +$4.43M |
|
|
17
American Well
AMWL
$111M
| $9.15M | 3.14% |
+727,600
| New | +$9.15M |
|
|
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.01M | 2.06% |
161,125
| – | – |
|
|
CANO
19
DELISTED
Cano Health, Inc.
CANO
| $6M | 2.06% |
496,100
| – | – |
|
|
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $4.87M | 1.67% |
377,775
+37,700
| +11% | +$486K |
|
|
21
Privia Health
PRVA
$2.83B
| $4.26M | 1.46% |
+96,000
| New | +$4.26M |
|
22
Guardant Health
GH
$8.41B
| $3.51M | 1.2% |
28,260
| – | – |
|
23
Seer Inc
SEER
$115M
| $2.74M | 0.94% |
83,500
| – | – |
|
24
Kymera Therapeutics
KYMR
$2.95B
| $1.8M | 0.62% |
+37,000
| New | +$1.8M |
|
25
C4 Therapeutics
CCCC
$185M
| $1.79M | 0.61% |
+47,200
| New | +$1.79M |
|